Yeh CT - Search Results

1

The Evolving Interplay among Abundant Adipokines in Patients with Hepatitis C during Viral Clearance.

Chang ML, Hsu CM, Lin CH, Lin CY, Kuo CJ, Huang SW, Chen CW, Cheng HT, Yeh CT, Chiu CT. Chang ML, et al. Among authors: yeh ct. Nutrients. 2017 Jun 2;9(6):570. doi: 10.3390/nu9060570. Nutrients. 2017. PMID: 28574439 Free PMC article.

2

Identification of a novel pre-S2 mutation in a subgroup of chronic carriers with spontaneous clearance of hepatitis B virus surface antigen.

Yeh CT, Chang MH, Lai HY, Chang ML, Chu CM, Liaw YF. Yeh CT, et al. J Gastroenterol Hepatol. 2003 Oct;18(10):1129-38. doi: 10.1046/j.1440-1746.2003.03146.x. J Gastroenterol Hepatol. 2003. PMID: 12974898

3

Characterization of a HCV NS5A protein derived from a patient with hepatoma.

Yeh CT, Chang MH, Shyu WC, Chang ML, Yang PY, Tsao ML, Lai HY. Yeh CT, et al. Biochem Biophys Res Commun. 2005 Feb 11;327(2):516-22. doi: 10.1016/j.bbrc.2004.11.165. Biochem Biophys Res Commun. 2005. PMID: 15629144

4

Virus and transaminase levels determine the emergence of drug resistance during long-term lamivudine therapy in chronic hepatitis B.

Chang ML, Chien RN, Yeh CT, Liaw YF. Chang ML, et al. Among authors: yeh ct. J Hepatol. 2005 Jul;43(1):72-7. doi: 10.1016/j.jhep.2005.02.021. Epub 2005 Apr 26. J Hepatol. 2005. PMID: 15896869

5

Emergence of mutation clusters in the HCV genome during sequential viral passages in Sip-L expressing cells.

Hwang DR, Lai HY, Chang ML, Hsu JT, Yeh CT. Hwang DR, et al. Among authors: yeh ct. J Virol Methods. 2005 Nov;129(2):170-7. doi: 10.1016/j.jviromet.2005.05.026. J Virol Methods. 2005. PMID: 16005986

6

Comparison of murine cirrhosis models induced by hepatotoxin administration and common bile duct ligation.

Chang ML, Yeh CT, Chang PY, Chen JC. Chang ML, et al. Among authors: yeh ct. World J Gastroenterol. 2005 Jul 21;11(27):4167-72. doi: 10.3748/wjg.v11.i27.4167. World J Gastroenterol. 2005. PMID: 16015684 Free PMC article.

7

A novel ex vivo assay of interferon-based suppression, to predict the outcome of antiviral therapy for hepatitis C.

Yeh CT, Hsu CW, Chang ML, Sheen IS, Lin SM, Lin CJ, Lin CC, Chen YC, Chen JC. Yeh CT, et al. J Infect Dis. 2006 May 15;193(10):1365-70. doi: 10.1086/503749. Epub 2006 Apr 12. J Infect Dis. 2006. PMID: 16619183

8

Emergence and takeover of precore-stop mutant prior to exacerbation of e antigen-negative chronic hepatitis B after withdrawal of lamivudine therapy.

Yeh CT, Lin WP, Hsu CW, Chang ML, Lin SM, Sheen IS. Yeh CT, et al. J Med Virol. 2006 Jul;78(7):906-10. doi: 10.1002/jmv.20639. J Med Virol. 2006. PMID: 16721857

9

Identification of NV-F virus DNA in hepatocellular carcinoma.

Yeh CT, Chen TC, Chang ML, Hsu CW, Yeh TS, Lee WC, Huang SF, Tsai CC. Yeh CT, et al. Among authors: yeh ts. J Med Virol. 2007 Jan;79(1):92-6. doi: 10.1002/jmv.20763. J Med Virol. 2007. PMID: 17133558

10

Identification of a hepatitis B virus S gene mutant in lamivudine-treated patients experiencing HBsAg seroclearance.

Hsu CW, Yeh CT, Chang ML, Liaw YF. Hsu CW, et al. Among authors: yeh ct. Gastroenterology. 2007 Feb;132(2):543-50. doi: 10.1053/j.gastro.2006.12.001. Epub 2006 Dec 3. Gastroenterology. 2007. PMID: 17258721

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

622 results

Search Page

Filters